annb0t
Top 20
It hasn't been the best quarter for Cyclopharm Limited (ASX:CYC) shareholders, since the share price has fallen 13% in that time. On the bright side the share price is up over the last half decade. In that time, it is up 36%, which isn't bad, but is below the market return of 46%. While the long term returns are impressive, we do have some sympathy for those who bought more recently, given the 27% drop, in the last year.
With that in mind, it's worth seeing if the company's underlying fundament...
>>> Read more: Cyclopharm's (ASX:CYC) investors will be pleased with their favorable 42% return over the last five years
With that in mind, it's worth seeing if the company's underlying fundament...
>>> Read more: Cyclopharm's (ASX:CYC) investors will be pleased with their favorable 42% return over the last five years